The survival risk ratios (SRRs) were calculated using linked hospitalisation and mortality data from New South Wales (NSW), Australia. Hospital admissions was obtained from the NSW Ministry of Health
Introduction: Sclerostin is an osteocyte-derived inhibitor of bone formation and is increased in kidney failure. Sclerostin might be involved in the pathogenesis of vascular calcification, but few stu